Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Irving

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Frontline Gastroenterology|August 26, 2017
Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?R J Dart, N Griffin, K Taylor, et al.
Clinical Medicine (London, England)|April 30, 2011
Poster presentations at medical conferences: an effective way of disseminating research?J R Goodhand, C L Giles, M Wahed, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 15, 2015
Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndromeL Whigham, T Joyce, G Harper, et al.
Neurogastroenterology and Motility|July 15, 2017
Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndromeM O'Keeffe, C Jansen, L Martin, et al.
Frontline Gastroenterology|August 26, 2017
Utilisation of anti-TNF levels in a UK tertiary IBD centreE L Johnston, B D Warner, J L Digby-Bell, et al.
Biochemical Pharmacology|June 18, 2013
Mechanism of allopurinol induced TPMT inhibitionP A Blaker, M Arenas-Hernandez, M A Smith, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2010
Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colonJ S Barrett, R B Gearry, J G Muir, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factorsM G Ward, B Warner, N Unsworth, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2013
Factors associated with thiopurine non-adherence in patients with inflammatory bowel diseaseJ R Goodhand, N Kamperidis, B Sirwan, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 27, 2011
Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel diseaseN Kamperidis, J R Goodhand, F A Chowdhury, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontline Gastroenterology|August 26, 2017
Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?R J Dart, N Griffin, K Taylor, et al.
Clinical Medicine (London, England)|April 30, 2011
Poster presentations at medical conferences: an effective way of disseminating research?J R Goodhand, C L Giles, M Wahed, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 15, 2015
Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndromeL Whigham, T Joyce, G Harper, et al.
Neurogastroenterology and Motility|July 15, 2017
Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndromeM O'Keeffe, C Jansen, L Martin, et al.
Frontline Gastroenterology|August 26, 2017
Utilisation of anti-TNF levels in a UK tertiary IBD centreE L Johnston, B D Warner, J L Digby-Bell, et al.
Biochemical Pharmacology|June 18, 2013
Mechanism of allopurinol induced TPMT inhibitionP A Blaker, M Arenas-Hernandez, M A Smith, et al.
Alimentary Pharmacology & Therapeutics|January 28, 2010
Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colonJ S Barrett, R B Gearry, J G Muir, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2017
Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factorsM G Ward, B Warner, N Unsworth, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2013
Factors associated with thiopurine non-adherence in patients with inflammatory bowel diseaseJ R Goodhand, N Kamperidis, B Sirwan, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 27, 2011
Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel diseaseN Kamperidis, J R Goodhand, F A Chowdhury, et al.
Pageof 3